Awards Nomination 20+ Million Readerbase
PMC/PubMed Indexed Articles
Bioavailability of Oral Hydrocortisone Corrected for Binding Proteins and Measured by LC-MS/MS Using Serum Cortisol and Salivary Cortisone
Crude Edible Fig ( Ficus carica) Leaf Extract Prevents Diethylstilbestrol (DES)-Induced DNA Strand Breaks in Single-Cell Gel Electrophoresis (SCGE)/Comet Assay: Literature Review and Pilot Study

View More »

Google Scholar citation report
Citations : 4890

Journal of Bioequivalence & Bioavailability received 4890 citations as per Google Scholar report

Journal of Bioequivalence & Bioavailability
Journal of Bioequivalence & Bioavailability peer review process verified at publons
Journal of Bioequivalence & Bioavailability
Indexed In
  • Academic Journals Database
  • Open J Gate
  • Genamics JournalSeek
  • Academic Keys
  • JournalTOCs
  • China National Knowledge Infrastructure (CNKI)
  • CiteFactor
  • Scimago
  • Ulrich's Periodicals Directory
  • Electronic Journals Library
  • RefSeek
  • Hamdard University
  • EBSCO A-Z
  • OCLC- WorldCat
  • SWB online catalog
  • Virtual Library of Biology (vifabio)
  • Publons
  • MIAR
  • University Grants Commission
  • Geneva Foundation for Medical Education and Research
  • Euro Pub
  • Google Scholar
View More
Useful Links
Share This Page
Journal Flyer
Journal of Bioequivalence & Bioavailability
Open Access Journals
View More

Vaccaro N

Vaccaro N

Senior Clinical Pharmacology Scientist / Technology, Process, Infrastructure Lead at Janssen.

Biography
Dr.Vaccaro N is currently working in Senior Clinical Pharmacology Scientist / Technology, Process, Infrastructure Lead at Janssen, Pharmaceutical Companies of Johnson and Johnson.Had experience in the pharmaceutical industry, specifically in Phase I clinical trials, and currently pursuing an advanced degree in Regulatory Affairs for Drugs, Biologics, and Medical Devices. Therapeutic areas of experience include, cardiovascular/metabolism, oncology, infectious diseases, women's health, and immunology. Experience in over 100+ clinical trials in all phases of drug development conducted in numerous study populations. Responsible Scientist in the successful submissions of INVOKANA and DORIBAX, and contributor to a number of other regulatory submissions.
Research Interest
Clinical trials, Drug regulatory affairs,Cardiovascular/metabolism, oncology, Infectious diseases, women's health, Immunology.